Microsoft R&D increased by 4.8% to $8.92B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 8.7%, from $8.20B to $8.92B. Over 4 years (FY 2021 to FY 2025), R&D shows an upward trend with a 11.9% CAGR.
Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.
Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...
Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.
research_and_development| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.69B | $5.60B | $5.76B | $6.31B | $6.85B | $6.63B | $6.84B | $6.98B | $6.74B | $6.66B | $7.14B | $7.65B | $8.06B | $7.54B | $7.92B | $8.20B | $8.83B | $8.15B | $8.50B | $8.92B |
| QoQ Change | — | -1.5% | +2.8% | +9.5% | +8.6% | -3.2% | +3.3% | +2.0% | -3.5% | -1.2% | +7.3% | +7.2% | +5.3% | -6.4% | +4.9% | +3.5% | +7.7% | -7.7% | +4.4% | +4.8% |
| YoY Change | — | — | — | — | +20.4% | +18.4% | +18.9% | +10.8% | -1.6% | +0.5% | +4.4% | +9.6% | +19.5% | +13.3% | +10.9% | +7.1% | +9.6% | +8.0% | +7.4% | +8.7% |